CHARACTERIZATION OF TSC PROTEIN HAMARTIN AND TUBERIN
TSC 蛋白错构瘤蛋白和马铃薯蛋白的表征
基本信息
- 批准号:6647745
- 负责人:
- 金额:$ 17.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:Drosophilidae carcinogenesis disease /disorder model gene expression gene mutation human subject laboratory mouse loss of heterozygosity neoplastic growth neoplastic transformation neuromuscular junction northern blottings patient oriented research polymerase chain reaction protein protein interaction protein structure function tuberous sclerosis tumor suppressor proteins
项目摘要
DESCRIPTION (provided by applicant): Tuberous sclerosis complex is multisystem
disorder characterized by the widespread development of growths known as
hamartomas in many tissues and organs, particularly within the brain, eyes,
skin, kidneys, heart, lungs and skeleton. The most severely affected system is
the central nervous system with the occurrence in affected individuals of
seizures (80-90 percent), mental retardation (50-60 percent), and autism (up to
50 percent). TSC is inherited as an autosomal dominant disorder, but
approximately two-thirds of affected patients are sporadic due to new germline
mutations. Genetic linkage studies have shown locus heterogeneity for the
disease, with at least two TSC determining genes on chromosomes 9 and 16 which
have been termed TSC1 and TSC2 respectively. The TSC1 gene encodes a novel
protein, hamartin that contains a single transmembrane domain and a large
cytoplasmic tail with a coiled-coil domain. The TSC2 gene encodes a novel
protein tuberin that contains a region of homology to the GTPase activating
protein rap1GAP. We have performed a comprehensive mutational analysis of the
TSC1 and TSC2 genes and noted that TSC1 mutations are significantly
underrepresented in sporadic patients. However, the occurrence of the second
somatic mutation in TSC lesions, particularly brain lesions is not clear. In
order to understand whether this is due to cellular pleomorphism, or if
haploinsufficiency of tuberin/hamartin is enough to promote tumor genesis, we
will perform genetic analysis on laser capture microdissected lesions. We have
identified a novel protein associated with Myc named Pam as an interacting
protein for tuberin. Mutations in both the Drosophila (hiw) and C. elegans
(rpm-1) homologs of Pam show synaptic overgrowth. Our hypothesis that Pam is an
essential component of the tuberin-hamartin complex, particularly in the CNS
where these proteins may have a critical role in cortical neuron function will
be examined. The domain of Pam that interacts with tuberin reveals 90 percent
similarity with the fly homolog HIW. The possible physical and genetic
interaction between the Drosophila TSC2 product Gigas and HIW will be examined.
Thus the studies aimed at defining the role of tuberin-hamartin in the
mammalian CNS will be further strengthened by the Drosophila model system where
genetic manipulations are possible. The information obtained here will
elucidate the physiological functions of these tumor suppressors, which will
aid in designing better therapies.
描述(由申请人提供):多发性硬化症是多系统的
一种以广泛生长为特征的疾病,
许多组织和器官中的错构瘤,特别是在脑,眼,
皮肤、肾脏、心脏、肺和骨骼。受影响最严重的系统是
中枢神经系统与受影响个体的发生
癫痫发作(80- 90%),精神发育迟滞(50- 60%),自闭症(高达
50%)。TSC是一种常染色体显性遗传疾病,
大约三分之二的受影响患者是散发性的,
突变。遗传连锁研究表明,
疾病,在9号和16号染色体上具有至少两个TSC决定基因,
分别称为TSC 1和TSC 2。TSC 1基因编码一种新的
蛋白质,包含单个跨膜结构域和一个大的
具有卷曲螺旋结构域的胞质尾区。TSC 2基因编码一种新的
一种蛋白质,含有一个与GT3激活蛋白同源的区域
rap 1GAP蛋白。我们已经进行了全面的突变分析,
TSC 1和TSC 2基因,并指出TSC 1突变是显着的,
在散发患者中代表性不足。然而,第二次的发生
TSC病变,特别是脑病变中的体细胞突变尚不清楚。在
为了了解这是否是由于细胞多形性,或者如果
tuberin/hamartin的单倍不足足以促进肿瘤发生,我们
将对激光捕获的显微切割病变进行遗传分析。我们有
发现了一种与Myc相关的新型蛋白质,名为Pam,作为相互作用蛋白
蛋白质为块茎素。果蝇(hiw)和C. elegans
(rpm-1)Pam的同源物显示突触过度生长。我们假设帕姆是
结核菌素-错构菌素复合物的基本成分,尤其是在中枢神经系统中
这些蛋白质可能在皮层神经元功能中起关键作用,
接受检查。与块茎素相互作用的Pam结构域显示90%
与苍蝇同源物HIW相似。可能的生理和遗传因素
将检测果蝇TSC 2产物Gigas和HIW之间的相互作用。
因此,这些研究旨在确定结核菌素-错构瘤蛋白在抗肿瘤治疗中的作用。
哺乳动物中枢神经系统将进一步加强果蝇模型系统,
基因操作是可能的。在此获得的信息将
阐明这些肿瘤抑制因子的生理功能,
帮助设计更好的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIJAYA RAMESH其他文献
VIJAYA RAMESH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIJAYA RAMESH', 18)}}的其他基金
NF2-associated meningiomas: From omics discovery to targeted therapy
NF2 相关脑膜瘤:从组学发现到靶向治疗
- 批准号:
10408180 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
NF2-Associated Meningiomas: From Omics Discovery to Targeted Therapy
NF2 相关脑膜瘤:从组学发现到靶向治疗
- 批准号:
10640996 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
NF2-associated meningiomas: From omics discovery to targeted therapy
NF2 相关脑膜瘤:从组学发现到靶向治疗
- 批准号:
10249966 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:
Genes that deregulate mTOR signaling as candidates for autism spectrum disorders
解除 mTOR 信号传导的基因作为自闭症谱系障碍的候选基因
- 批准号:
7488759 - 财政年份:2007
- 资助金额:
$ 17.3万 - 项目类别:
Genes that deregulate mTOR signaling as candidates for autism spectrum disorders
解除 mTOR 信号传导的基因作为自闭症谱系障碍的候选基因
- 批准号:
7304882 - 财政年份:2007
- 资助金额:
$ 17.3万 - 项目类别:
2006 NF Consortium for NF1, NF2 and Schwannomatosis
2006 NF1、NF2 和神经鞘瘤病联盟
- 批准号:
7162767 - 财政年份:2006
- 资助金额:
$ 17.3万 - 项目类别:
CHARACTERIZATION OF TSC PROTEIN HAMARTIN AND TUBERIN
TSC 蛋白错构瘤蛋白和马铃薯蛋白的表征
- 批准号:
6931449 - 财政年份:2001
- 资助金额:
$ 17.3万 - 项目类别:
相似海外基金
Prevention of Radiation-Induced Carcinogenesis by Senolytics
通过 Senolytics 预防辐射诱发的致癌作用
- 批准号:
23H03539 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of Prostaglandin D Receptor-mediated Carcinogenesis Mechanism of Colitic Cancer
前列腺素D受体介导的结肠癌致癌机制的阐明
- 批准号:
23K08219 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
- 批准号:
23K05734 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis
微生物群与幽门螺杆菌在胃癌发生中的相互作用
- 批准号:
10709135 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Pathways of Injury and Repair in Barrett's Carcinogenesis
巴雷特癌发生过程中的损伤和修复途径
- 批准号:
10713938 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Spatial transcriptomic research on carcinogenesis and progression of lung cancer with interstitial pneumonia
肺癌合并间质性肺炎发生发展的空间转录组学研究
- 批准号:
23K14468 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER
结对卓越,战略性地推进致癌和癌症研究
- 批准号:
10050740 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
EU-Funded
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
骨髓细胞驱动胰腺可塑性和致癌机制
- 批准号:
10607213 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别: